Elanco Animal Health, Inc. (ELAN)
24.14
-0.35
(-1.43%)
USD |
NYSE |
Aug 28, 14:23
Elanco Animal Health Cash from Operations (Quarterly) : 277.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 277.00M |
| March 31, 2026 | 13.00M |
| December 31, 2025 | 108.00M |
| September 30, 2025 | 219.00M |
| June 30, 2025 | 237.00M |
| March 31, 2025 | -4.00M |
| December 31, 2024 | 177.00M |
| September 30, 2024 | 162.00M |
| June 30, 2024 | 200.00M |
| March 31, 2024 | 2.00M |
| December 31, 2023 | 157.00M |
| September 30, 2023 | 198.00M |
| June 30, 2023 | 61.00M |
| March 31, 2023 | -145.00M |
| December 31, 2022 | 13.00M |
| September 30, 2022 | 189.00M |
| June 30, 2022 | 312.00M |
| Date | Value |
|---|---|
| March 31, 2022 | -62.00M |
| December 31, 2021 | 223.00M |
| September 30, 2021 | 89.00M |
| June 30, 2021 | 149.00M |
| March 31, 2021 | 22.00M |
| December 31, 2020 | -92.90M |
| September 30, 2020 | -111.70M |
| June 30, 2020 | 159.30M |
| March 31, 2020 | 4.30M |
| December 31, 2019 | 126.30M |
| September 30, 2019 | 39.60M |
| June 30, 2019 | 52.60M |
| March 31, 2019 | 5.60M |
| December 31, 2018 | 139.50M |
| September 30, 2018 | 163.90M |
| June 30, 2018 | 136.90M |
| March 31, 2018 | 47.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Zoetis, Inc. | 655.00M |
| Eli Lilly & Co. | 10.69B |
| ANI Pharmaceuticals, Inc. | 56.67M |
| EyePoint, Inc. | -62.35M |
| Amylyx Pharmaceuticals, Inc. | -31.42M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -110.00M |
| Cash from Financing (Quarterly) | -74.00M |
| Free Cash Flow | 379.00M |
| Free Cash Flow Per Share (Quarterly) | 0.4823 |
| Free Cash Flow to Equity (Quarterly) | 317.00M |
| Free Cash Flow to Firm (Quarterly) | 307.64M |
| Free Cash Flow Yield | 3.13% |